A Phase 1 Study Assessing Local Cutaneous Effects of SB204

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Novan, Inc.

Criteria

Inclusion Criteria:

• Healthy volunteers

Exclusion Criteria:

• Women who are pregnant or nursing

• Subject with known sensitivity to a component of the test materials